Protocol Builder
Explore a sample RSV vaccine effectiveness study
RSV Vaccine Effectiveness in Older Adults: A Real-World Evidence Study
in reviewUpdated 1/20/2026
What is the real-world vaccine effectiveness of the RSVPreF (Abrysvo) vaccine against RSV-associated lower respiratory tract disease in adults aged 60 years and older during the 2025-2026 respiratory season?
Want to create your own protocols?
Sign up for free to unlock all features.